Cannabidiol (CBD) – potential billion dollar market, but still barriers in the legal framework
Be up to date – don’t miss your investment opportunity, but also be aware of the barriers
nova Session “CBD (cannabidiol) as a food additive, body care and pharmaceutical – effects, production, authorisation and legislation”
17 September 2019, 10:00-16:30 h
Wöllhaf Conference Center
Terminal 1, Airport Cologne/Bonn, Germany
Terminal 1, Airport Cologne/Bonn, Germany

Leading experts from Great Britain, Germany, Italy and Brussels, all members of the European Industrial Hemp Association, will bring you up to date and discuss with you extensively. Join in, learn, discuss and share.
Michael Carus, nova-Institut (DE)
|
Daniel Kruse, Managing Director of HempConsult and EIHA board member (DE)
|
Joscha Krauss, MH MedicalHemp (DE)
|
Lorenza Romanese, Managing Director of EIHA (IT/BE)
|
Catherine Wilson, CannaWellness and EIHA board member (UK)
|
Participants are welcome to submit their specific topics of interest beforehand or put them up for discussion at the session. |